Glaxosmith Kline Consumer Nigeria Plc has recorded revenue of N16.447 billion at the end of third quarter financial year, ended September 30, 2020
The nine month result released by the company showed that the revenue rose by 3.34 per cent from N15.915 billion reported in preceding year.
An analysis of the company result showed that cost of sales up by 6.01 per cent to N12.028 billion from N11.346 billion recorded in the same period of 2019 while gross profit declined by 3.30 per cent from N4.569 billion to N4.418 billion reported in the preceding year.
Investment income also went down by 62.05 per cent to N63.04 million from N166.12 million in the 2019
